HLF Q4 2025 Earnings Call Summary | Stock Taper
Logo
HLF

HLF — Herbalife Nutrition Ltd.

NYSE


Q4 2025 Earnings Call Summary

February 19, 2026

Summary of Herbalife Ltd. Q4 2025 Earnings Call

1. Key Financial Results and Metrics

  • Q4 Net Sales: $1.3 billion, up 6.3% year-over-year, marking the second consecutive quarter of growth and exceeding guidance (1.5% to 5.5%).
  • Full Year Net Sales: Just over $5 billion, nearly a 1% increase; adjusted for foreign exchange (FX), net sales grew 2.5%.
  • Q4 Adjusted EBITDA: $156 million, exceeding guidance of $144 million to $154 million, with a margin of 12.2%.
  • Full Year Adjusted EBITDA: $658 million, with a margin of 13.1%, reflecting expansion for the second consecutive year.
  • Operating Cash Flow: $333 million for the year, up 17% from 2024.
  • Debt Repayment: $283 million in 2025, reducing total leverage ratio from 3.9x to 2.8x.

2. Strategic Updates and Business Highlights

  • Distributor Growth: North America saw a 19% increase in new distributors, with Latin America achieving its seventh consecutive quarter of growth.
  • Product Innovation: Successful launches in 2025 included MultiBurn for weight management and HL/Skin in EMEA. The company is focusing on expanding its product portfolio to align with consumer trends.
  • Digital Transformation: The Pro2col health and wellness operating system is being rolled out to enhance distributor engagement and customer support. Beta testing is ongoing, with plans for broader access in 2026.
  • Partnership with Cristiano Ronaldo: Ronaldo acquired a 10% stake in HBL Pro2col Software, investing $7.5 million, which is expected to elevate brand visibility and support the personalized nutrition initiative.

3. Forward Guidance and Outlook

  • Q1 2026 Guidance: Expected net sales growth of 3% to 7% year-over-year, including a 250 basis point tailwind from currency. Adjusted EBITDA is projected between $155 million to $175 million.
  • Full Year 2026 Guidance: Anticipated net sales growth of 1% to 6% (including a 100 basis point currency tailwind) and adjusted EBITDA between $670 million to $710 million.

4. Bad News, Challenges, or Points of Concern

  • China Market Decline: Net sales in China decreased by 4% year-over-year, primarily due to an 11% drop in volume, with expectations for continued challenges in 2026.
  • GST Impact in India: The reduction in GST rates has a net negative impact of approximately $16 million on margins due to changes in service fees, which could affect profitability despite driving volume growth.
  • Distributor Recruitment Trends: While there was a decline in new distributors globally (down 5% year-over-year), the two-year stack shows a 16% increase, indicating some volatility in recruitment.

5. Notable Q&A Insights

  • Regional Sales Expectations: While growth is expected in all regions except China, detailed regional guidance was not provided. India is anticipated to benefit from the GST reduction until it laps in late 2026.
  • Pro2col Sales Contribution: Minimal revenue from Pro2col is built into 2026 guidance as it is still in beta testing, but there is optimism for future upside.
  • Distributor Events: Increased spending on distributor events is expected in 2026, reflecting a commitment to enhancing distributor engagement and training.
  • Consumer Base Expansion: The company aims to attract a more sophisticated customer base while supporting existing customers through personalized nutrition solutions.

Overall, Herbalife demonstrated a strong financial performance in Q4 2025, with strategic initiatives focused on innovation, digital transformation, and distributor engagement positioning the company for future growth, despite facing challenges in specific markets and operational adjustments.